EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Bradmer Pharmaceuticals Inc. (T.GLX) EBITDA Margin data is not available.
| Income Statement Financials | |
-- |
|
-0.35M |
|
-- |
|
-- |
|
-- |
|
-0.35M |
|
-- |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
-0.35M |
|
0.16M |
|
0.16M |
|
-2.24 |
|
-2.24 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
0.34M |
|
-- |
|
-- |
|
-- |
|
0.41M |
|
-0.07M |
|
-0.07M |
|
-0.07M |
|
0.16M |
|
| Cash Flow Statement Financials | |
-0.07M |
|
-- |
|
-- |
|
0.40M |
|
0.34M |
|
-0.07M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
-0.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
486.53% |
|
486.53% |
|
-100.58% |
|
486.53% |
|
-0.46 |
|
-0.44 |
|
-0.44 |
|